Asgard Therapeutics
Asgard Therapeutics is a Biotechnology Company.
Operating in biotechnology, therapeutics based in European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA), Asgard Therapeutics was founded in 2018.
Its activity falls under biotechnology, therapeutics; the profile below is assembled from public directory data.
The business is associated with European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA).
Its current recorded stage is Series_A.
Its team size is recorded as c_00001_00010 employees.
It has disclosed roughly $36M in funding.
| Sector | Biotechnology, Therapeutics |
|---|---|
| Headquarters | European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA) |
| Founded | 2018 |
| Employees | c_00001_00010 |
| Stage | series_a |
| Total funding | $36,000,000 |
Website: www.asgardthx.com
Sign in to view the contact information we hold for Asgard Therapeutics.
Create a free account
Create a free account